284 related articles for article (PubMed ID: 30110674)
1. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
[TBL] [Abstract][Full Text] [Related]
2. Association of time-averaged serum uric acid level with clinicopathological information and long-term outcomes in patients with IgA nephropathy.
Weng M; Fu B; Zhuo Y; Lin J; Zou Z; Chen Y; Cui J; Li G; Chen C; Xu Y; Jiang D; Wan J
PeerJ; 2024; 12():e17266. PubMed ID: 38650643
[TBL] [Abstract][Full Text] [Related]
3. [Retrospective Analysis of the Effect of Uric Acid on the Prognosis of Immunoglobulin A Nephropathy With Stage 3-4 Chronic Kidney Disease].
Yu Z; Qin Y; Yuan J; Zhao J; Sun S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1121-1127. PubMed ID: 38162075
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.
Yang B; Zhou W; Cui L; Tian L; Ni Y; Yang M; Yang Y
Front Endocrinol (Lausanne); 2024; 15():1372824. PubMed ID: 38808109
[TBL] [Abstract][Full Text] [Related]
5. Plasma uric acid level indicates tubular interstitial leisions at early stage of IgA nephropathy.
Zhou J; Chen Y; Liu Y; Shi S; Li X; Wang S; Zhang H
BMC Nephrol; 2014 Jan; 15():11. PubMed ID: 24423013
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic features aid in predicting risk for progression of IgA nephropathy.
Walsh M; Sar A; Lee D; Yilmaz S; Benediktsson H; Manns B; Hemmelgarn B
Clin J Am Soc Nephrol; 2010 Mar; 5(3):425-30. PubMed ID: 20089495
[TBL] [Abstract][Full Text] [Related]
7. Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up.
Cheng GY; Liu DW; Zhang N; Tang L; Zhao ZZ; Liu ZS
Clin Nephrol; 2013 Jul; 80(1):40-6. PubMed ID: 23391320
[TBL] [Abstract][Full Text] [Related]
8. Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
Mohd R; Mohammad Kazmin NE; Abdul Cader R; Abd Shukor N; Wong YP; Shah SA; Alfian N
PLoS One; 2021; 16(4):e0249592. PubMed ID: 33831052
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
Liu S; Lu Z; Fu Z; Li H; Gui C; Deng Y
Kidney Blood Press Res; 2023; 48(1):186-193. PubMed ID: 37062274
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
[TBL] [Abstract][Full Text] [Related]
11. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.
Myllymäki J; Honkanen T; Syrjänen J; Helin H; Rantala I; Pasternack A; Mustonen J
Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382
[TBL] [Abstract][Full Text] [Related]
12. Uric acid and long-term outcomes in CKD.
Madero M; Sarnak MJ; Wang X; Greene T; Beck GJ; Kusek JW; Collins AJ; Levey AS; Menon V
Am J Kidney Dis; 2009 May; 53(5):796-803. PubMed ID: 19303683
[TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking and progression of IgA nephropathy.
Yamamoto R; Nagasawa Y; Shoji T; Iwatani H; Hamano T; Kawada N; Inoue K; Uehata T; Kaneko T; Okada N; Moriyama T; Horio M; Yamauchi A; Tsubakihara Y; Imai E; Rakugi H; Isaka Y
Am J Kidney Dis; 2010 Aug; 56(2):313-24. PubMed ID: 20471735
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
Terinte-Balcan G; Stancu S; Zugravu A; Capusa C; Radu A; Mircescu G; Stefan G
J Nephrol; 2023 Nov; 36(8):2233-2243. PubMed ID: 37632668
[TBL] [Abstract][Full Text] [Related]
15. Serum uric acid levels and long-term outcomes in chronic kidney disease.
Miyaoka T; Mochizuki T; Takei T; Tsuchiya K; Nitta K
Heart Vessels; 2014 Jul; 29(4):504-12. PubMed ID: 23929090
[TBL] [Abstract][Full Text] [Related]
16. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
[TBL] [Abstract][Full Text] [Related]
17. Uric acid-based ratios for predicting renal failure in Chinese IgA nephropathy patients.
Qin A; Yang D; Wang S; Dong L; Tan J; Tang Y; Qin W
Int J Med Sci; 2023; 20(12):1584-1591. PubMed ID: 37859692
[No Abstract] [Full Text] [Related]
18. Association of C4d deposition with clinical outcomes in IgA nephropathy.
Espinosa M; Ortega R; Sánchez M; Segarra A; Salcedo MT; González F; Camacho R; Valdivia MA; Cabrera R; López K; Pinedo F; Gutierrez E; Valera A; Leon M; Cobo MA; Rodriguez R; Ballarín J; Arce Y; García B; Muñoz MD; Praga M;
Clin J Am Soc Nephrol; 2014 May; 9(5):897-904. PubMed ID: 24578331
[TBL] [Abstract][Full Text] [Related]
19. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
[TBL] [Abstract][Full Text] [Related]
20. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.
Zhang J; Wang C; Tang Y; Peng H; Ye ZC; Li CC; Lou TQ
Nephrology (Carlton); 2013 Feb; 18(2):125-31. PubMed ID: 23134230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
